Cytonome is a biotechnology engineering and manufacturing company that designs and develops cutting edge cell sorting platforms. We offer powerful application-specific technology for the cell therapy, life science and industrial markets. We work closely with our partners to understand their needs and provide their ideal solution. Cytonome was founded in 2009 on the premise of providing advanced solutions for cell purification needs. By developing cutting edge technologies in cell purification and platform design, Cytonome provides novel solutions for cell therapy, research and industry. With deep engineering expertise in the cytometry field and an expansive intellectual property portfolio, Cytonome aims to develop products that simplify existing workflows and enable leading edge advances and research. Now, it is easier than ever to obtain purified cell populations in your lab for downstream applications.
Cytonome possesses an expansive portfolio of intellectual property, with 97 issued patents in a variety of technical areas, with particular focus on microfluidics. A further 59 patent applications are pending.
The Cytonome Team is made up of experienced professionals with a deep and diverse knowledge and expertise in engineering, biology, manufacturing, project management, quality and marketing.